A Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006)

Conditions

• Clostridium Difficile Infection

Interventions

• DRUG: CB-183,315
• DRUG: Vancomycin
• DRUG: Placebo

Sponsor

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)